Amgen Inc. (NASDAQ:AMGN) is seeing shares trade up another 2% pre-market after yesterday’s decision where an FDA panel rejected a proposal to set a specific target for red blood-cell levels in kidney-failure…
Amgen (NASDAQ:AMGN) has a huge day ahead of it. The biotech giant is presenting data today on the appropriateuse of Erythropoiesis Stimulating Agents in Chronic RenalFailure patients to a joint meeting of…
Amgen (NASDAQ:AMGN) has seen a slight recovery of late, mostly on reports that the U.S. Senate is asking Centers for Medicaid and Medicare Services to reconsider the drastically cut reimbursement rates. Shares…
Stock Tickers: AXP, AMZN, BIIB, BNI, CME, DD, HAL, LMT, MRK, PEP, T These may not be the ONLY important earnings, but we wanted to hit most of the major earnings. It…
AYE raised to Buy at Jefferies.BIIB cut to Equal Weight at Lehman.CELG raised to Overweight at Lehman.CKNN started as Buy at Merriman Curhan Ford.CMG started as Equal-Weight at Lehman.DLB raised to Overweight…
Biogen Idec inc. (BIIB-NASDAQ) is trading up roughly 4% pre-market at $51.40, within striking distance of its $52.72 high over the last year on news of a share buyback plan. That is…
Douglas A. McIntyre (AAPL) Apple trading up 0.5% after Morgan Stanley raised its $110 target to $150.(BGP) Borders Group posted a -$0.51 EPS loss vs. -$0.38e.(BIIB) Biogen Idec announced up to $3 Billion in share…
Stock Tickers: AMGN, GILD, CELG, GENZ, MEDI, BIIB, AMLN, IMCL, DNDN, NFLD The short interest is on the rise overall, but the odd thing is that the short interest in biotech shares…